News
Astellas to acquire iota Biosciences following R&D partnership
Japanese pharma Astellas will acquire bioelectronics firm iota after announcing a research and development agreement last year.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Japanese pharma Astellas will acquire bioelectronics firm iota after announcing a research and development agreement last year.